This website uses cookies to ensure you get the best experience on our website.
Accept Cookies
Learn More
Green Journals
Home
Hijacked
Contact Us
More
Simulation
Green Recruitments
About Us
Blog
Login
Register
English
English
Français
العربية
Journal Report
LANCET
Download PDF
Print
Journal Information
Journal Title
LANCET
Publisher
ELSEVIER SCIENCE INC
ISSN
0140-6736
E-ISSN
1474-547X
Database
Clarivate
Domain
Health Sciences, Physical Sciences, Social Sciences
Classification History
Year
A+
A
B
C
2026
✓
✓
2025
✓
✓
2024
✓
✓
2023
✓
✓
2021/2022
✓
✓
2020
✓
✓
2019
✓
✓
✓
2018
✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
WHO should adjust its cervical cancer plan
Eric J Suba
2026-10
Vol. 408
Issue 10564
Pages 1549-1550
DOI:
10.1016/s0140-6736(26)01641-7
Establishing cardiovascular safety of the small-molecule GLP-1 receptor agonist orforglipron in type 2 diabetes
Yu Mi Kang, Michael A Nauck
2026-10
Vol. 408
Issue 10564
Pages 1526-1527
DOI:
10.1016/s0140-6736(26)02045-3
Preserving the uterus: an effective dual therapy to avoid hysterectomy
Maria Julia Lemos, Jose Carugno
2026-10
Vol. 408
Issue 10566
Pages 1790-1792
DOI:
10.1016/s0140-6736(26)01715-0
8 weeks versus 12 weeks of sofosbuvir–velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India
Amit Goel, Sumit Rungta, Vinod Kumar et al.
2026-10
Vol. 408
Issue 10564
Pages 1593-1602
DOI:
10.1016/s0140-6736(26)01380-2
Irritable bowel syndrome and related disorders of gut–brain interaction
Christopher J Black, Kee Huat Chuah, Yasmin Nasser et al.
2026-10
DOI:
10.1016/s0140-6736(26)01500-x
Thirlwall, Bier's spots, and the Letby murders
Sam Shuster
2026-10
Vol. 408
Issue 10566
Pages 1811
DOI:
10.1016/s0140-6736(26)02031-3
Hepatitis C—is discrimination preventing elimination?
Graham R Foster, John Dillon, Rachel Halford
2026-10
DOI:
10.1016/s0140-6736(26)01917-3
Izalontamab brengitecan for HR+/HER2– breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial
Bo Lan, Yehui Shi, Xiying Shao et al.
2026-10
DOI:
10.1016/s0140-6736(26)02096-9
Richard Dadd's beguiling art
Stephen Ginn
2026-10
Vol. 408
Issue 10566
Pages 1806-1807
DOI:
10.1016/s0140-6736(26)02080-5
Whose vitiligo goes untreated?
Magrietha Swart, Zunaid Ahmed, Willem I Visser
2026-10
Vol. 408
Issue 10566
Pages 1812
DOI:
10.1016/s0140-6736(26)02090-8
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: October 30, 2026 11:18